Avantor (NYSE:AVTR) PT Raised to $25.00

Avantor (NYSE:AVTR) had its price objective upped by analysts at Deutsche Bank Aktiengesellschaft from $23.00 to $25.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 3.73% from the company’s previous close.

A number of other equities analysts have also weighed in on the stock. Raymond James boosted their price target on shares of Avantor from $22.50 to $26.00 and gave the stock an “outperform” rating in a research report on Friday, January 26th. Barclays boosted their price target on shares of Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 10th. Robert W. Baird boosted their target price on shares of Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Citigroup boosted their target price on shares of Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Finally, Royal Bank of Canada boosted their target price on shares of Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, Avantor has an average rating of “Moderate Buy” and an average price target of $26.71.

Avantor Stock Performance

AVTR opened at $24.10 on Thursday. The firm has a market capitalization of $16.35 billion, a PE ratio of 50.21, a PEG ratio of 1.53 and a beta of 1.37. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16. The firm’s 50-day moving average price is $24.93 and its 200 day moving average price is $22.46. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00.

Avantor (NYSE:AVTR) last posted its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.03. The firm had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. Avantor’s quarterly revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.32 earnings per share. As a group, sell-side analysts expect that Avantor will post 1.01 EPS for the current fiscal year.

Insider Activity

In other news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the sale, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.50% of the company’s stock.

Institutional Investors Weigh In On Avantor

Large investors have recently added to or reduced their stakes in the business. Fifth Third Bancorp increased its stake in Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock worth $28,000 after buying an additional 694 shares during the period. Quarry LP purchased a new stake in Avantor during the 4th quarter worth approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt increased its stake in Avantor by 565.5% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock worth $30,000 after buying an additional 1,131 shares during the period. Gladius Capital Management LP purchased a new stake in Avantor during the 4th quarter worth approximately $42,000. Finally, Montag A & Associates Inc. purchased a new stake in Avantor during the 4th quarter worth approximately $43,000. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.